Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Epilepsy × Fentanyl × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 12 Neoplasms 6 Colonic Neoplasms 5 Agnosia 5 Lung Neoplasms 4 Cancer Pain 4 Breast Neoplasms 4 Rectal Neoplasms 3 Prostatic Neoplasms 3 Pain, Postoperative 3 Head and Neck Neoplasms 3 Urinary Bladder Neoplasms 2 Sarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pleural Effusion, Malignant 2 Pancreatic Neoplasms 2 Lymphoma, Follicular 2 Diverticulosis, Colonic 2 Chronic Pain 2 Breakthrough Pain 2 post laminectomy syndrome 1 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Thrombocythemia, Essential 1 Terminal Cancer 1 Sezary Syndrome 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1

Interventions

Sirolimus 4 Everolimus 3 Anticonvulsants 2 ziprasidone 1 perampanel 1 enzalutamide 1 clevidipine 1 brivaracetam 1 Zolpidem 1 Warfarin 1 Vigabatrin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Tobramycin 1 Therapeutic Touch 1 Temozolomide 1 Surgical Procedures, Operative 1 Sulfasalazine 1 Spironolactone 1 Sevoflurane 1 Sevelamer 1 Saline Solution 1 Rocuronium 1 Registries 1 Radiotherapy 1 Propofol 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07165262 2025-09-10

ECOG-Anaes

Children's Cancer Hospital Egypt 57357

Phase 3 Active not recruiting

Brain Neoplasms, Epilepsy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡